Literature DB >> 32142718

Systematic review of the roles of interleukins in hepatocellular carcinoma.

Hu Yang1, Yang Xuefeng2, Xiao Jianhua3.   

Abstract

Hepatocellular carcinoma (HCC) is a primary liver cancer with high morbidity and mortality that is often accompanied by immune system disorders and local lymphocyte infiltration. Tumor-infiltrating lymphocytes, cancer cells, stromal cells, and the numerous cytokines they produce, such as chemokines, interferons, tumor necrosis factors, and interleukins, collectively constitute the tumor microenvironment. As a main type of immune effector, interleukin plays opposing roles in regulating tumor cell progression, adhesion, and migration according to its different subtypes. Many reports have concentrated on the roles that interleukins play in HCC, but understanding them systematically remains challenging. This study reviewed the current data to comprehensively summarize the relationships between HCC progression and human interleukin gene families.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  CTL (cytotoxic T lymphocyte); Hepatocellular carcinoma; Interleukin; Tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32142718     DOI: 10.1016/j.cca.2020.03.001

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma.

Authors:  Yakun Wang; Lei Yang; Xichen Dong; Xin Yang; Xinxue Zhang; Zhe Liu; Xin Zhao; Tao Wen
Journal:  Biomed Res Int       Date:  2020-12-23       Impact factor: 3.411

Review 2.  Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis.

Authors:  Qing Pu; Lihua Yu; Xinhui Wang; Huiwen Yan; Yuqing Xie; Yuyong Jiang; Zhiyun Yang
Journal:  J Cancer       Date:  2022-09-06       Impact factor: 4.478

Review 3.  Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.

Authors:  Chuang Xi; Guo-Qiang Zhang; Zhen-Kui Sun; Hong-Jun Song; Chen-Tian Shen; Xiao-Yue Chen; Jian-Wen Sun; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.